Voluntary announcement - on-market share repurchase under the general mandate
Filed with HKEX · Stock code 2192 · · 2 pages · English
Summary by 6ix AI
Medlive Technology Co., Ltd. has made a voluntary announcement regarding its share repurchase program. The company has commenced repurchasing its own shares on the open market under a mandate granted by shareholders. The board believes that the current share price does not reflect the company's long-term value and will conduct repurchases prudently. All repurchases will be funded by the company's internal resources and will be held as treasury shares. Shareholders should exercise caution as the timing and volume of repurchases are at the board's discretion based on market conditions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Medlive Technology Co., Ltd. on 6ix
Earlier from Medlive Technology
- Next Day Disclosure Return
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim report 2026
- (1) Renewal of continuing connected transactions and (2) increase of monetary cap for continuing connected transactions
Later from Medlive Technology
All Medlive Technology news releasesFollow Medlive Technology into a list and get an email when it puts out news.
Follow Medlive Technology